Like
Share
멍실장
고양이 종양 면역 치료 자주 묻는 질문 Q&A — 보호자가 꼭 알아야 할 핵심

What Is Feline Tumor Immunotherapy? — Essential Q&A for Pet Owners on Principles to Efficacy

Oncology/CancerQ&AMeongsiljang Veterinary Advisory Board

We’ve compiled five essential questions every pet owner should know about the core principles, practical application, side effects, and efficacy of tumor immunotherapy in cats.

What Is Feline Tumor Immunotherapy?

A microscopic view of immune cells attacking cancer cells
Feline tumor immunotherapy is a treatment approach that strengthens the immune system’s ability to recognize and attack cancer cells on its own. - Immune system activation: This helps immune cells identify abnormal antigens (neoantigens) present on cancer cells as foreign substances, thereby triggering an attack. - Utilization of antitumor immunity: While this method enhances the immune cells’ antitumor response, it may cause immune-related side effects and is often insufficient as a standalone treatment, so it is frequently used in combination with other therapies. - Specific response and immune memory: By targeting tumor antigens, this approach causes relatively less damage to normal cells, and the resulting immune memory can help reduce the risk of recurrence. - Treatment goals: The primary objectives are to suppress tumor growth and extend survival time, with the treatment plan customized based on the cat’s overall health status.

Why Can Immunotherapy Be Effective for Feline Tumors?

A cat’s immune system can recognize cancer cells, but tumors often evade immune attacks through immune evasion mechanisms. - Inhibition of immune evasion: Immune checkpoint inhibitors (such as PD-1/PD-L1 and CTLA-4 blockers) interrupt these evasion mechanisms, helping exhausted immune cells regain their ability to attack the tumor. - Potential for targeted attack: By utilizing cytotoxic T cells that recognize tumor-specific neoantigens, this approach causes relatively less damage to healthy cells. - Expectation of long-term effects: Once immunological memory is established, long-term remission has been reported in some cases. - Limitations of response: Not all tumors respond to immunotherapy, and if immune cells are too exhausted to recover, the treatment’s efficacy may be limited or the disease may recur. - Broadening treatment options: This therapy complements the limitations of conventional treatments, expanding the range of options for tumor management.
This explains how immune cells recognize and attack cancer cells, as well as the mechanism of immune checkpoint blockade.

What Are the Main Types of Immunotherapy?

Immunotherapy includes immune checkpoint inhibitors, antibody therapy, vaccine therapy, and cell therapy. - Immune checkpoint inhibitors: These block the PD-1/PD-L1 pathway to reinvigorate immune cell attacks. - Antibody therapy: Antibodies bind to specific antigens on the surface of cancer cells, either recruiting immune cells or directly destroying the cancer cells. - Vaccine therapy: This approach induces an immune response by incorporating tumor-specific antigens from the cat. - Cell therapy: T cells are extracted, expanded, and then reinfused, offering a personalized treatment option. The choice of therapy depends on the tumor characteristics and the cat's overall condition.
A veterinarian administering an immunotherapy injection to a cat.

Comparison of Characteristics by Immunotherapy Type

ItemTypeMechanism of ActionMain AdvantagePrecautions
Immune Checkpoint InhibitorsBlocking the PD-1/PD-L1 pathwayActivation of immune cellsPotential for long-term effectPossibility of immune-related side effects
Antibody TherapyBinding to specific antigens on the cancer cell surfaceDirect cell destructionPrecise targetingHigh cost, limited response rate
Vaccine TherapyInducing an immune response via cancer cell antigensPotential for preventive effectHigh safetyLimited therapeutic effect

Treatment selection is determined by the veterinarian based on the tumor type, condition, and the cat's overall health.

How Much Effectiveness Can Be Expected from Immunotherapy?

The effectiveness of immunotherapy varies depending on the tumor type, stage of progression, and strength of the immune response. - Variable responses: While tumor stabilization or long-term remission has been reported in some cases, responses to the same immunotherapy can differ between tumors, and not all tumors respond. - Relationship to survival: Long-term remission may be observed in patients who respond well to treatment, but survival time varies significantly based on tumor type and stage, making it difficult to provide a uniform estimate. - Potential for preventing recurrence: The formation of immune memory may reduce the risk of recurrence. - Predictors of response: Factors such as the degree of immune cell infiltration within the tumor and its molecular and genetic characteristics can help predict treatment response. - Significant individual variation: Not all cats respond to immunotherapy, so pre-treatment evaluation is essential.
A cat resting comfortably by a sunlit window

Visit the Clinic Immediately If Abnormal Symptoms Occur During Immunotherapy

If your pet shows signs of fatigue, loss of appetite, vomiting, diarrhea, fever, or skin rashes, it could indicate an excessive immune response or side effects. Please consult your veterinarian immediately.

What Should Be Considered Alongside Immunotherapy?

Immunotherapy stimulates a systemic immune response, so it’s essential to carefully monitor your cat’s overall health. - Nutritional support: Adequate protein and nutrient intake are vital for supporting the immune response. - Minimizing stress: Stress can suppress immune function, so providing a calm, stable environment is important. - Regular check-ups: Frequent veterinary visits help detect any adverse symptoms or changes in vital signs early. - Communication with your veterinarian: Maintain ongoing dialogue with your vet before and during treatment to adjust the plan based on your cat’s response. - The role of the family: Your careful observation and record-keeping play a significant part in the success of the treatment.
A veterinarian and a cat owner are looking at a medical chart and having a conversation.

Reviewed by a veterinarian

Dr. Tony — Punnawat Phongkittirak

Dr. Tony — Punnawat Phongkittirak

Veterinarian

A veterinarian who majored in veterinary medicine at Khon Kaen University, Thailand, and completed the IVSA program at North Carolina State University in the United States. Drawing on clinical experience at animal hospitals, he works in the pet healthcare field and is dedicated to building a digital care environment that connects pet parents with veterinarians.

Frequently Asked Questions

Does immunotherapy cause pain in cats?
The injection itself is virtually painless. However, as a result of the immune response following treatment, your pet may experience fatigue or a fever. These are temporary symptoms.
When can we expect to see the effects of immunotherapy?
The timing of the response varies significantly depending on the type of tumor and the individual pet. Immunotherapy often takes time to show its effects, so changes in tumor size are typically assessed after a certain period, making it difficult to pinpoint a specific timeframe for everyone.
Can immunotherapy be used alongside other treatments?
Yes, it can be used in combination with radiation therapy or chemotherapy. In some cases, monoclonal antibody therapy alone may not be sufficient, so other treatments are added to complement it. However, because side effects can accumulate, a veterinarian’s judgment is essential.
What are the side effects of immunotherapy?
Possible side effects include fatigue, decreased appetite, vomiting, diarrhea, skin rashes, and immune-related conditions. Most are mild and temporary, but immune-related adverse reactions require close monitoring.
What should I do if immunotherapy isn’t working?
If there is no response to treatment or if the condition worsens, it is necessary to reevaluate the treatment plan with your veterinarian and switch to a different therapy.

Share

Related Guides

References

[1] Rassnick KM, Williams LE, Kristal O et al. (2008) Lomustine for treatment of mast cell tumors in cats: 38 cases (1999-2005). Journal of the American Veterinary Medical Association 232, 1200-1205.

[2] Lee, W.S., Yang, H., Chon, H.J. and Kim, C. (2020) Combination of anti-angiogenic therapy and immune checkpoint blockade normalizes vascular-immune crosstalk to potentiate cancer immunity. Experimental & Molecular Medicine 52(9), 1475–1485.

[3] Mitchell, L., Thamm, D.H. and Biller, B.J. (2012) Clinical and immunomodulatory effects of toceranib combined with low-dose cyclophosphamide in dogs with cancer. Journal of Veterinary Internal Medicine 26(2), 355–362.

This information is based on veterinary literature and does not replace diagnosis or treatment. Please consult a veterinarian for specific health concerns.

Metapet Co., Ltd. | CEO: Park Sung-yong | Business Reg. No. 417-88-02562 | Seoul, South Korea | Customer Center

What Is Feline Tumor Immunotherapy? Principles to Efficacy | Meongsiljang